Where does Jmea Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Jmea Corporation ranks #14,708 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Jmea Corporation hold?

Jmea Corporation holds 20 US utility patents granted between 2015 and 2025, spanning 2 technology areas.

What is Jmea Corporation's Innovation Score?

Jmea Corporation has an Innovation Score of 34.0 out of 100 (46th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Jmea Corporation focus on?

Jmea Corporation's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 13 patents, ranking #1,352 of 7,127 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

Is Jmea Corporation's patent grant rate increasing or decreasing?

Jmea Corporation's recent grant velocity is -27% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Jmea Corporation's patents?

Jmea Corporation's patents average 22.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Jmea Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Jmea Corporation

USPTO PatentsView assignee record - 20 granted patents across 2 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Jmea ranks #14,708 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 2 technology areas.

#14,708
of 49,997 US assignees by volume: 46th percentile
by Innovation Score (34.0/100): 22.0
avg claims per patent: -27%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14708 · US Corporation #14,708 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #14,708/49,997
PHOTO-FINISH JAC Operations
CPC-NARROW A61B · 2 areas
INNOV-THIN 34.0/100
CLAIMS-DENSE 22.0 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -27% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: JAC Operations, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Jmea’s 34.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (31%) Velocity 5.3 pts (16%) Breadth 5.0 pts (15%) Claim depth 13.2 pts (39%)

Qualcomm Incorporated · highest

85
Jmea · this assignee

34
3D Lighting… · lowest

7

What this shows Jmea's Innovation Score is 34.0/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Jmea?

Each dot is one of Jmea’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Jmea’s own 22.0 claims/patent is ABOVE the 16.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Jmea vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Jmea's grants concentrate

Jmea Corporation is a focused PatentsView assignee: 2 CPC subclasses with 65% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2019. By volume, Jmea sits between J.W. Medical Systems Ltd. and Johnson Controls Autobatterie GmbH & Co. KGaA.

Jmea's three-year grant acceleration

Jmea Corporation shows 4 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

J W Medical Syste…

20
JAC Operations

20
Jawaharlal Nehru…

20
Jingning Meige Te…

20
Jost-werke Deutsc…

20
JST Power Equipme…

20
Janssen Biopharma

20
Johnson Controls…

20
Jmea ◀

20

What this shows Jmea holds 20 patents at rank #14,704, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Jmea

By rank, the assignees closest to #14,704 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Jmea's primary technology class.

Jmea's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 46th percentile higher than 46% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Jmea Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	15.0%
2016	3	15.0%
2017	2	10.0%
2018	2	10.0%
2019	1	5.0%
2020	3	15.0%
2021	1	5.0%
2022	1	5.0%
2023	1	5.0%
2024	2	10.0%
2025partial year	1	5.0%

Which technologies does Jmea Corporation patent most?

A61B - DIAGNOSIS; SURGERY; Identification 13

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 11

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Jmea Corporation's patent record in context - here's where to go next.

Jmea Corporation's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 65% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #14,708 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Jmea Corporation against J.W. Medical Systems Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.